YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease
Authors:
Open Access
- 27 November 2024
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (1) , 331-348
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogrammingActa Pharmaceutica Sinica B, 2022
- Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstaclesActa Pharmaceutica Sinica B, 2021
- Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cellsActa Pharmaceutica Sinica B, 2021
- The role of microglia in the development of neurodegenerationNeurological Sciences, 2020
- The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammationEBioMedicine, 2019
- Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic TargetMolecular Neurobiology, 2016
- Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue lightBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Synaptic degeneration in Alzheimer’s diseaseActa Neuropathologica, 2009
- MYH9‐siRNA and MYH9 mutant alleles: Expression in cultured cell lines and their effects upon cell structure and functionCell Motility, 2008
- Mechanism and function of deubiquitinating enzymesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004